Cite
HARVARD Citation
Petitcollin, A. et al. (2019). Pharmacokinetic Parameters of Infliximab Influence the Rate of Relapse After De‐Escalation in Adults With Inflammatory Bowel Diseases. Clinical pharmacology & therapeutics. 106 (3), pp. 605-615. [Online].